Impact of phenotypic rapid diagnostic assay on duration of empiric antibiotics for gram-negative bacteremia

7Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Objective: Rapid diagnostic tests (RDTs) are increasingly being implemented as antimicrobial stewardship tools to facilitate antibiotic modification and reduce complications related to their overutilization. We measured the clinical impact of a phenotypic RDT with antimicrobial stewardship (AMS) in the setting of gram-negative bacteremia. Setting and participants: In this single-center retrospective cohort study, we evaluated adult patients with gram-negative bacteremia who received at least 72 hours of an antibiotic. Methods: The primary outcome was the duration of empiric antibiotic therapy for gram-negative bacteremia. Secondary outcomes included time-to-directed therapy, proportion of modifications, hospital length of stay (LOS), and subsequent infection with a multidrug-resistant organism (MDRO) or C. difficile infection (CDI). Results: The duration of empiric antibiotics decreased in the RDT+AMS group (4 days vs 2 days; P

Cite

CITATION STYLE

APA

Mohayya, S. M., Arsalan, M., Narayanan, N., Patel, P., Hong, C. G., Kirn, T. J., … Bhowmick, T. (2023). Impact of phenotypic rapid diagnostic assay on duration of empiric antibiotics for gram-negative bacteremia. Antimicrobial Stewardship and Healthcare Epidemiology, 3(1). https://doi.org/10.1017/ash.2022.331

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free